Clinical Advances in the Diagnosis and Treatment of Atrial Fibrillation

Dear Colleagues,

The prevalence of atrial fibrillation (AF) increases with age, affecting over 28% of patients > 85 years. However, there have been significant advancements in both the diagnosis and treatment of this condition over recent years. Major diagnostic improvements are centered around the integration of technology, with the adoption of wearable devices and smartphone apps that allow for the continuous monitoring and detection of arrhythmias in real time. These tools have enhanced early detection rates, especially in asymptomatic patients, and have improved the patient engagement and self-management of the condition.

Advances in treatment strategies established newer anticoagulants such as direct oral anticoagulants (DOACs) which have become preferred over traditional warfarin due to their better safety profiles and ease of use, without the need for regular blood monitoring. Moreover, catheter ablation, which uses radiofrequency energy or ballon-based cryoablation to isolate pulmonary veins and other selected areas in the heart to prevent AF episodes, has improved in safety and efficacy. Several clinical studies suggest better rhythm control for catheter ablation compared to anti-arrhythmic therapy. Invasive procedures have also benefited from technological advancements such as improved three-dimensional mapping systems or pulsed-field ablation technology, enhancing the success rates and reducing complications.

Furthermore, there has been a growing focus on personalized treatment approaches. This involves tailoring interventions based on individual risk profiles and underlying conditions, improving patient outcomes and reducing the burden of AF on healthcare systems. These clinical advances have significantly contributed to a more effective and efficient management of atrial fibrillation.

Prof. Dr. Urs Eriksson
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• atrial fibrillation
• early detection
• treatment strategies
• personalized treatment approaches